Burns J, Arnold J H
MICU Office, Children's Hospital, Boston, MA 02115.
Curr Opin Pediatr. 1994 Jun;6(3):295-302. doi: 10.1097/00008480-199406000-00011.
The search for more effective therapies and techniques directed toward shock and resuscitation continues to be the subject of extensive research in the critical care literature. One area of intense focus is the hypothesis that nonsurvivors with poor oxygen delivery can be converted to survivors if their oxygen delivery variables are maximized. Based on recent controlled clinical trials, this remains controversial. In addition, the notion of monoclonal antibody as the magic bullet for endotoxin-induced septic shock is undergoing reexamination. New techniques to supplement basic cardiopulmonary resuscitation continue to be evaluated, but so far survival outcomes are not significantly different from the standard technique introduced over 30 years ago. Finally, debate continues on the efficacy of ribavirin in the treatment of otherwise well infants mechanically ventilated for respiratory syncytial virus infection.
寻找针对休克和复苏的更有效疗法和技术仍然是重症监护文献中广泛研究的主题。一个备受关注的领域是这样一种假说:如果将氧输送变量最大化,那么氧输送不佳的非幸存者可以转变为幸存者。基于最近的对照临床试验,这一观点仍存在争议。此外,单克隆抗体作为治疗内毒素诱导的感染性休克的神奇药物这一概念正在重新审视中。补充基本心肺复苏的新技术仍在评估中,但到目前为止,生存结果与30多年前引入的标准技术相比并无显著差异。最后,关于利巴韦林治疗因呼吸道合胞病毒感染而接受机械通气的健康婴儿的疗效争论仍在继续。